Plain-English translation of NCT07160270 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers want to learn more about nerve damage (called neuropathy) that sometimes happens in people with Waldenström's macroglobulinemia, a type of blood cancer. This study will examine about 90 patients to understand how common this nerve damage is, what symptoms people experience, and what blood markers might help doctors predict and manage it better.
Nerve damage is a known complication in some people with Waldenström's macroglobulinemia, but doctors don't fully understand how often it happens, why it develops, or the best way to diagnose it. This research aims to fill that gap so doctors can catch and treat nerve damage earlier.
You likely qualify if…
You likely don't qualify if…
You'll first complete a questionnaire about any nerve-related symptoms. If your answers suggest possible nerve damage, you'll be invited for a full day of testing at the hospital: a neurological exam by a trained doctor, a nerve conduction study (a painless electrical test of your nerves), additional questionnaires about quality of life, and blood tests. Some patients may also have a lumbar puncture (spinal tap). The whole study lasts one year, and doctors will follow up with you for three more years after that.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
Denmark